Evidence map›Paper›PMID 41143281›Full record

ArticleTechnical innovations & patient support in radiation oncology2025

Evaluating participant experiences and tolerability with MR Linac imaging.

Jayde Nartey, Helen A McNair, Katie Biscombe, Sophie E Alexander, Charlotte Cherry, Cynthia Eccles, Trina Herbert, Shaista Hafeez, Kelly Jones, Francesca Mason and 5 more

Abstract read
In one paragraph

Article in Technical innovations & patient support in radiation oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Jayde NarteyThe Royal Marsden NHS Foundation Trust, London, the United Kingdom of Great Britain and Northern Ireland.
Helen A McNairThe Royal Marsden NHS Foundation Trust, London, the United Kingdom of Great Britain and Northern Ireland.
Katie BiscombeThe Institute of Cancer Research, London, the United Kingdom of Great Britain and Northern Ireland.
Sophie E AlexanderThe Royal Marsden NHS Foundation Trust, London, the United Kingdom of Great Britain and Northern Ireland.
Charlotte CherryThe Royal Marsden NHS Foundation Trust, London, the United Kingdom of Great Britain and Northern Ireland.
Cynthia EcclesThe Christie NHS Foundation Trust, Department of Radiotherapy, Manchester, the United Kingdom of Great Britain and Northern Ireland.
Trina HerbertThe Royal Marsden NHS Foundation Trust, London, the United Kingdom of Great Britain and Northern Ireland.
Shaista HafeezThe Royal Marsden NHS Foundation Trust, London, the United Kingdom of Great Britain and Northern Ireland.
Kelly JonesThe Royal Marsden NHS Foundation Trust, London, the United Kingdom of Great Britain and Northern Ireland.
Francesca MasonThe Royal Marsden NHS Foundation Trust, London, the United Kingdom of Great Britain and Northern Ireland.
Simeon NillThe Royal Marsden NHS Foundation Trust, London, the United Kingdom of Great Britain and Northern Ireland.
Hosna MohammadThe Royal Marsden NHS Foundation Trust, London, the United Kingdom of Great Britain and Northern Ireland.
Kian MorrisonThe Royal Marsden NHS Foundation Trust, London, the United Kingdom of Great Britain and Northern Ireland.
Bethany WilliamsThe Royal Marsden NHS Foundation Trust, London, the United Kingdom of Great Britain and Northern Ireland.
Robert HuddartThe Royal Marsden NHS Foundation Trust, London, the United Kingdom of Great Britain and Northern Ireland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Magnetic Resonance Image Guided Radiotherapy (MRIgRT) integrates MRI with a linear accelerator to enable adaptive treatment delivery. While technical feasibility is well established, patient experience during MR Linac imaging, especially outside treatment sessions, remains underexplored. This study evaluates tolerability, pre-scan anxiety, coping ability, willingness for future scans, and scan-induced symptoms in patients and non-patient volunteers. Materials and Methods: Participants who successfully underwent MR Linac imaging between November 2017 and December 2023 completed a bespoke MR Linac Participant Experience Questionnaire, developed by the PRIMER study team and informed by MRI patient experience literature. The questionnaire assessed pre-scan anxiety, coping, willingness for future scans, and scan-related symptoms using Likert-scale responses. Descriptive analyses summarised responses by participant group and anatomical site. Results: In total, 447 participants (319 patients; 128 non-patient volunteers) completed MR Linac imaging and the questionnaire. Overall tolerability was high, with 65 % strongly disagreeing they felt anxious prior to scanning and most participants reporting good coping ability. Variability was observed across anatomical sites: Participants undergoing head and neck, brain, and oligometastatic bone scans reported higher pre-scan anxiety, with coping difficulties most frequently reported by the head and neck group. Non-patient volunteers reported more physiological symptoms (e.g., sweating, nausea, dizziness) than patients, whereas patients undergoing head and neck and bone oligometastases scans were more reluctant to repeat the procedure. Most patients perceived MR Linac imaging as easier or comparable to diagnostic MRI, though 20 % of brain cancer patients found it more difficult. Conclusion: MR Linac imaging is generally well tolerated, though specific subgroups, particularly those requiring immobilisation, report greater anxiety and discomfort. These findings highlight the need for tailored strategies to improve patient experience, supporting wider implementation of MRIgRT.

Indexed as

MRI-guided radiotherapyMR LinacScan anxietyTolerability

Identifiers

PMID41143281
PMCPMC12547962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.